DeJarnette Research Systems has signed a letter of intent to acquire radiology information system (RIS) firm Swearingen Software of Houston. The purchase builds on the two firms’ partnership, announced last December at the RSNA (SCAN Special
DeJarnette Research Systems has signed a letter of intent to acquire radiology information system (RIS) firm Swearingen Software of Houston. The purchase builds on the two firms partnership, announced last December at the RSNA (SCAN Special Report 1/99). Towson, MD-based DeJarnette hopes Swearingen will strengthen DeJarnettes position in the PACS and RIS markets. No financial terms of the transaction were released.
DeJarnette will integrate Swearingen Softwares RMS RIS into Radiance, its PACS product line. DeJarnette hopes to begin shipping Radiance by the end of the year. Swearingen will remain at its Houston headquarters, although its sales, marketing, and business operations will be combined with DeJarnettes Towson offices. Company president Randall Swearingen will become vice president of information systems and operations for DeJarnette. DeJarnette does not expect any layoffs or cancellations of existing products as a result of the purchase.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.